Trial Profile
A Study to Evaluate the Efficacy of Infliximab Therapy and Predictors of Response in Patients With Ulcerative Colitis (UC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 02 Mar 2016 New trial record
- 26 Feb 2016 Results published in the Digestive Diseases and Sciences